International disruptions to cancer diagnosis and stage at presentation during the COVID-19 pandemic in 2020: an International Cancer Benchmarking Partnership (ICBP) population-based study.

Saved in:
Bibliographic Details
Title: International disruptions to cancer diagnosis and stage at presentation during the COVID-19 pandemic in 2020: an International Cancer Benchmarking Partnership (ICBP) population-based study.
Authors: Morgan E; Cancer Surveillance Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France. Electronic address: morgane@iarc.who.int., Bardot A; Cancer Surveillance Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France., Langselius O; Cancer Surveillance Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France., Rutherford MJ; Cancer Surveillance Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France; Division of Public Health & Epidemiology, School of Medical Sciences, University of Leicester, Leicester, UK., Elkader HA; Te Aho o Te Kahu, Cancer Control Agency, Wellington, New Zealand., Bennett D; Northern Ireland Cancer Registry, Queen's University Belfast, Centre for Public Health, School of Medicine, Dentistry & Biomedical Sciences, Belfast, UK., Brennan A; National Cancer Registry Ireland, Cork, Ireland., Bucher O; Department of Epidemiology and Cancer Registry, CancerCare Manitoba, Winnipeg, MB, Canada., Butler J; Royal Marsden Hospital, London, UK; Cancer Research UK, London, UK., Cameron DA; Edinburgh University Cancer Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK., Canfell K; Cancer Elimination Collaboration, School of Public Health, University of Sydney, Sydney, NSW, Australia., Chiam K; Cancer Elimination Collaboration, School of Public Health, University of Sydney, Sydney, NSW, Australia; The Daffodil Centre, Sydney, NSW, Australia., Chiarelli A; Ontario Health, Toronto, ON, Canada., Creighton N; Cancer Institute NSW, Sydney, NSW, Australia., De P; Ontario Health, Toronto, ON, Canada., Evans S; Victorian Cancer Registry, Cancer Council Victoria, Melbourne, VIC, Australia., Fitzpatrick D; Northern Ireland Cancer Registry, Queen's University Belfast, Centre for Public Health, School of Medicine, Dentistry & Biomedical Sciences, Belfast, UK., Guren MG; Department of Oncology, Oslo University Hospital, University of Oslo, Oslo, Norway., Hannah J; Public Health Scotland, Edinburgh, UK., Huws DW; Welsh Cancer Intelligence and Surveillance Unit, Public Health Wales, Cardiff, UK., Jackson CGCA; Population Data Science, Swansea University Medical School, Swansea, UK; Faculty of Medicine, University of Otago, Dunedin, New Zealand., Kønig SM; Danish Cancer Institute, Danish Cancer Society, Copenhagen, Denmark., Kumar E; NB Cancer Network, Department of Health, Fredericton, NB, Canada., Larønningen S; Cancer Registry of Norway, Norwegian Institute of Public Health, Oslo, Norway., Lawler M; Johnston Cancer Research Centre, Queen's University Belfast, Belfast, UK., Liu Q; Te Aho o Te Kahu, Cancer Control Agency, Wellington, New Zealand., McClure C; PEI Cancer Registry, Health PEI, Charlottetown, PE, Canada., Mehmood A; NB Cancer Network, Department of Health, Fredericton, NB, Canada., Mitchell H; Northern Ireland Cancer Registry, Queen's University Belfast, Centre for Public Health, School of Medicine, Dentistry & Biomedical Sciences, Belfast, UK., Morrison DS; Public Health Scotland, Edinburgh, UK., Murray D; National Cancer Registry Ireland, Cork, Ireland; School of Public Health, University College Cork, Cork, Ireland., Norwood T; Ontario Health, Toronto, ON, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada., Phillips KAM; PEI Cancer Registry, Health PEI, Charlottetown, PE, Canada., Ransom D; Department of Health, Perth, WA, Australia., Shack L; Cancer Advanced Analytics, Health Shared Services, Calgary, AB, Canada; Cumming School of Medicine, University of Calgary, Calgary, AB, Canada., Smits S; Welsh Cancer Intelligence and Surveillance Unit, Public Health Wales, Cardiff, UK., Saint-Jacques N; Nova Scotia Health Cancer Care Program, Halifax, NS, Canada., Marvelde LT; Victorian Cancer Registry, Cancer Council Victoria, Melbourne, VIC, Australia., Tran D; Saskatchewan Cancer Registry, Saskatchewan Cancer Agency, Regina, SK Canada., Turner D; Department of Epidemiology and Cancer Registry, CancerCare Manitoba, Winnipeg, MB, Canada; College of Community and Global Health, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada., Ursin G; Cancer Registry of Norway, Norwegian Institute of Public Health, Oslo, Norway., Vernon S; NHS England, The Leeds Government Hub, Leeds, UK., Walker MJ; Ontario Health, Toronto, ON, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada., Woods RR; Population Health Sciences, BC Cancer, Vancouver, BC, Canada., Zhang B; NB Cancer Network, Department of Health, Fredericton, NB, Canada., Bray F; Cancer Surveillance Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France., Soerjomataram I; Cancer Surveillance Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
Source: The Lancet. Oncology [Lancet Oncol] 2026 Jun; Vol. 27 (6), pp. 738-750.
Publication Type: Journal Article
Journal Info: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1474-5488
DOI:10.1016/S1470-2045(26)00089-6